In Conversation

With COVID’s high demands and the drive for Co2 reductions, the maritime sector is growing in importance within the healthcare supply chain

The complexities of conditions like cancer demand a revolutionary solution. That is where CAR-T cell therapy could be a potential game-changer

Frontier markets, particularly in Africa, present great opportunities for setting up facilities for vaccine manufacturing and indeed entire biotech ecosystems

Belgian healthcare is under huge pressure to balance the costs associated with new innovations, but continual price cuts for generics are threatening the system’s sustainability and…

By investing so much in the Belgian ecosystem, we can be an important player on several fronts, leveraging the voice of the innovative industry

The only critical success factor in moving forward and getting innovative products reimbursed is for pharmaceutical companies to be seen as a real partner; a real…

Patients are the true experts as the only actors that know what living with a condition is like and the impact of a treatment on how…

In Belgium we are generally good at treating conditions but not so good at preventing them, and this is also the case with diabetes

Everybody needs to know how important phase I studies are in clinical research. Without them, there would be no new drugs or vaccines

Access is vital. Having the chance to find innovative treatments and then not making them available to patients would be a dramatic and ethically unacceptable situation

While we recognize the importance of innovation for the pharmaceutical landscape and the need to address unmet medical needs, we advocate for a fair and equal…

We are very proud to say that 30 percent of the eye drops sold in Belgium are Théa products

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here